Can 'self-confidence workshops' for depression help the implementation of the NICE Guidelines?

Not Applicable

Completed

• Conditions: Depression; Mental and Behavioural Disorders; Depressive episode

• Registration Number: ISRCTN26634837
• Lead Sponsor: King's College London (UK)

Brief Summary

1. 2014 results in: http://www.ncbi.nlm.nih.gov/pubmed/24357574 2. 2019 results in: https://www.ncbi.nlm.nih.gov/pubmed/30760305

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-10-06
• Study Completion: 2011-11-30
• Last Update Posted: 11 March 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 320

Inclusion Criteria

1. Depressed people, classified as only those with a Beck Depression Inventory (BDI) score of 14 and above
2. Aged 16 years or over, either sex

Exclusion Criteria

1. Aged less than 16 years
2. Attention problems or organic brain syndrome

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> 1. Client Service Receipt Inventory (CSRI): a specially designed short self-report version will be developed and used to assess service use and lost employment<br> 2. Beck Depression Inventory (BDI) for assessment of severity of depression. 4-point Likert scale to measure the extent to which the person is experiencing symptoms of depression.<br><br> Both measures completed at baseline and 3-month follow-up.<br>

Secondary Outcome Measures

Name	Time	Method
<br> 1. GAD-7 measure to assess how much the person has been bothered by various symptoms of anxiety on a 4-point Likert scale (0 not at all, 3 nearly every day)<br> 2. Rosenberg Self-Esteem Scale to assess feelings about self on a 4-point Likert scale (0 strongly disagree, 3 strongly agree)<br> 3. The EQ-5D measure of health outcome to enable health-related quality of life and quality-adjusted life-years to be calculated. Participants indicate how they are coping in terms of mobility, self-care, anxiety/depression, pain and completion of usual activities. Also uses a visual analogue scale for indicating health state (0 worst imaginable health state, 100 best imaginable health state).<br><br> All measures completed at baseline and 3-month follow-up.<br>